Department of Health

Key messages

  • A medical or nurse practitioner involved in a methadone or buprenorphine program must inform the department if a patient is terminated from a program.
  • There are several reasons for terminating a patient’s pharmacotherapy.
  • If an incarcerated patient is on a pharmacotherapy program and is released from prison, this must be notified in addition to the regular notification.

Approved medical practitioners or nurse practitioners need to notify the department if a patient’s participation in a methadone or buprenorphine program is terminated.

Reasons for a patient’s termination include:

  • transfer to another practitioner
  • hospitalisation
  • imprisonment
  • ceased to dose methadone or buprenorphine
  • requested to leave by doctor
  • did not start a program
  • discharged from hospital
  • released from prison
  • completed the program
  • deceased.

The notification of termination of a methadone or buprenorphine program is a requirement under the Drugs, Poisons and Controlled Substances Act 1981.

If an incarcerated patient is on a pharmacotherapy program and is released from prison, this must be notified in addition to the regular notification.

Reviewed 20 December 2021

Health.vic

Contact details

Department of Health and Human Services

Victorian Opioid Pharmacotherapy Program Drugs Policy and Reform

Was this page helpful?